Curative and Vytalize Expand Value-Based Care Access
Austin, Texas and Hoboken, New Jersey, August 17, 2026 Curative and Vytalize Health have finalized a major network agreement...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Austin, Texas and Hoboken, New Jersey, August 17, 2026 Curative and Vytalize Health have finalized a major network agreement...
PARAMUS, N.J., June 15, 2026 SK Life Science, Inc. has announced that the U.S. Food and Drug Administration (FDA)...
AMSTERDAM, Netherlands and BURBANK, Calif., May 28, 2026 Royal Philips and The Walt Disney Company have announced a groundbreaking...
Raleigh, N.C. | January 28, 2026 — Lumexa Imaging, one of the largest U.S. providers of outpatient diagnostic imaging...
Dateline — WALTHAM, Mass., November 11, 2025:Zenas BioPharma, Inc. (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company dedicated to developing...
